跳至主要内容
临床试验/ITMCTR2100005418
ITMCTR2100005418已完成1 期

Observation of clinical efficacy of Ying-Pi No.1 hand mask cream in the treatment of scleroderma

The First Affiliated Hospital of Zhejiang Chinese Medicine University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
28 至 78(—)
性别
All

入选标准

  • Patients who met the SSc classification diagnostic criteria of The American College of Rheumatology (ACR) in 2013(score 9 points) and whose skin involvement was in the stage of swelling and sclerosis.

排除标准

  • Patients with important organ involvement, such as pulmonary interstitial disease, pulmonary hypertension, pericardial effusion or hypertrophic inflammatory myopathy, need more than 0.5mg/kg/day glucocorticoid treatment; Patients with renal crisis; Patients with arteriovenous thrombosis and diabetes-related gangrene; Patients with SSC-related gangrene infection; Local skin is extensively damaged and cannot be applied externally.

研究者

发起方
The First Affiliated Hospital of Zhejiang Chinese Medicine University

相似试验